Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

12.70USD
16 Nov 2018
Change (% chg)

$0.11 (+0.87%)
Prev Close
$12.59
Open
$12.44
Day's High
$12.98
Day's Low
$12.26
Volume
293,013
Avg. Vol
198,265
52-wk High
$16.82
52-wk Low
$3.82

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $170.63
Shares Outstanding(Mil.): 41.42
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates